"The first phase of the plan will help ensure those most at risk - certain health care workers and first responders - have access to the vaccination", said Dr. Steven Stack, commissioner of KDPH.
The North American pharmaceutical company Pfizer hopes to request a emergency authorization for the use of your COVID-19 vaccine by the end of November, as announced on Thursday by the CEO of the company, Albert Bourla, in a open letter.
What's more, the company will also gather manufacturing data to demonstrate "the quality and consistency of the vaccine that will be produced", Bourla said.
Earlier this month, Bingham told the Financial Times that those who believe that everyone in the population will be vaccinated as soon as a vaccine becomes available are nurturing a "misguided perception". This disclosure did not appear to affect the development of the trials and the forecasts of both companies to obtain their vaccine against COVID-19 before the end of the year are maintained. Three were in Moderna's trial, while the other two were in Pfizer's.
Drugmakers have been more ambitious with their calculations.
"But by that time hopefully we can stem the acute impacts, reduce mortality, protect those who are at highest risk, " the expert said, according to Fox. Moderna has said it is on track to make around 20 million doses by the end of the year and between 500 million and 1 billion doses a year beginning in 2021.
Shah said that's just one of the distribution challenges, but nevertheless, they are working out scenarios based on the vaccines now in late-stage trials.
"Most people agree that it's starting with healthcare workers and frontline workers, but even there you need to define which of them are at the highest risk and then the elderly and so on", she said.
"So let me be clear, assuming positive data, Pfizer will apply for Emergency Authorisation Use in the United States soon after the safety milestone is achieved in the third week of November", the company's chairman and CEO Albert Bourla said in an open letter.
Fears of delays were raised after trials for two rival vaccines were put on hold in the United States in recent weeks.
Key areas addressed in the plan include enrollment of health care providers to administer vaccines, storage and handling, prioritization, allocation, distribution, and data reporting.
The Food and Drug Administration wants the vaccine to prove its effectiveness and safety, while Pfizer has to prove its ability to produce vaccine doses in large quantities.
French Health Workers Protest in Paris Demanding Better Working Conditions
The curfew aims to keep some 20 million people home from 9 pm to 6 am from Saturday - 30 percent of the French population. A further 88 people died in France after testing positive for Covid-19, according to the most recent daily figures.